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Abstract 
Apoptosis is an evolutionarily conserved cell death programme, serving to eliminate 
superfluous or damaged cells in tissue development and homeostasis. Intra- or extra-
cellular signals that instruct a cell to die converge upon activation of a group of 
proteases, named caspase. Proteolysis mediated by downstream effector caspase leads 
to controlled destruction of components, producing apoptotic phenotypes that 
characterize the execution phase. It is generally thought that the execution phase 
marks the point of no return, the assumption of which has been questioned by 
accumulating evidence. This thesis presents data demonstrating that cells have an 
intrinsic mechanism to survive apoptosis in execution phase and regain normal 
function. Importantly, the data show that the dying cells have initiated DNA 
damaging mechanisms and the survived cells have altered genetic content comparing 
to the untreated cells. Altogether this suggests the process of reversing apoptosis, 
which is termed reversal of apoptosis, as an intrinsic mechanism to generate genetic 
alterations in cells exposed to stress environment. At the end of the thesis, the 
mechanism of the reversal of apoptosis is discussed. A perspective on the role of this 






















1.1.1 Overview of apoptosis 
Apoptosis, also known as cell suicide, is a type of programmed cell death in which, 
upon receiving extra- or intra-cellular signals, a cell degrades its structures in an 
ordered manner (Taylor et al. 2008), preparing itself to be cleared by neighboring or 
immunity cells (Nagata et al. 2010). In metazoans, cell suicide mediates tissue 
development and homeostasis by removing abnormal, damaged or unnecessary cells 
(Jacobson et al. 1997; Conradt 2009), interpreted as a "self-sacrificing" process for 
the "greater good" of the whole cell population. Interestingly, apoptosis is 
evolutionary-conserved (Ameisen 2002; Deponte 2008), not only observed in human, 
mouse and drosophila, but also at least in nine species of unicellular organisms, such 
as yeast and slime molds. In the latter organisms, apoptosis is similarly understood as 
an altruistic process (Ameisen 2002; Gourlay et al. 2006; Deponte 2008), e.g. 
occurring in aged cells to maintain an optimal cell number of a population. In addition 
to its physiological and evolutionary significance, apoptosis has been an important 
target for medical intervention in diseases, most notably cancer. In cancer 
chemotherapy, drugs are applied in order to selectively induce apoptosis in cancerous 
cells without triggering necrotic death that can arouse a massive immune response 
(Brown et al. 2005). 
Given its pivotal and prevalent role in organism functioning, dysreulgation of 
apoptosis in humans can lead to dire medical conditions. For example, inactivation of 
apoptosis makes cells prone to accumulate DNA damage and thus fuel cancer 
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dcvclopiiicnt (Hanahan 2000). On the other hand, excessive apoptosis results in 
unwanted ccll loss, which is implicated diseases such as Alzheimer's diseases. The 
study presented here inquires into a possible gap of time between the point of 
commitment and the destruction phase of apoptosis and into the possible disastrous 
consequence from this gap. 
1.1.2 Synopsis of the apoptotic pathway 
Apoptosis was first morphologically characterized by (Kerr et al. 1972), as a cell 
deletion process with distinct cellular phenotypes, such as cytoplasmic and nuclear 
condensation, nuclear fragmentation and breaking up of a cell into apoptotic bodies. 
Further elaboration of the cellular and molecular process subdivides the apoptotic 
pathway into initiation and execution phases (Danial et al. 2004). During the initiation 
phase, intrinsic signals (conveyed by the release of cytochrome c from mitochondria 
into cytosol) or extrinsic signals, (triggered by binding of death receptors, such as 
FAS, TNF alpha) culminate in activation of a cascade of proteases named caspase, in 
which caspases are processed into active forms. While caspases in the upstream of the 
cascade, known as the initiators, are mainly responsible for activating downstream 
ones, the effector caspases (Kumar 1999; Riedl et al. 2004), the effectors mediate 
cleavage of a diverse array of substrates, including components in cytoskeleton, 
transcription and translation machinery, producing apoptotic phenotypes that are 
hallmarks of the execution phase (Taylor et al. 2008; Luthi et al. 2007). 
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1.1.3 l)efilling apoptosis 
As described above, since the first morphological characterization of 
apoptosis, decades of effort have been spent on deciphering the molecular 
mechanism. Although the apoptotic phenotypes are well established and effector 
caspases' substrates are being identified (Luthi et al. 2007), the causal relationship 
between the phenotypes and the proteolysis of a particular substrate remains 
unproven. Also, "apoptosis" is de facto a term describing a collection of cellular 
events produced by a heterogeneous set of underlying biochemical pathways 
(Kroemer et al. 2009). In other words, an apoptotic cell does not necessarily show a 
full repertoire of biochemical and cellular events. Well-known features like 
oligonucleosomal DNA degradation are not found universally in apoptotic cells and 
are unnecessary for the apoptotic death of a cell (Kawane et al. 2003; Ucker et al. 
1992; Schulze-Osthoff et al. 1994; Samejima et al. 2005). Similarly, some forms of 
programmed cell death are found to be caspase- independent though share some 
phenotypic similarities with apoptosis (Chipuk et al. 2005; Kroemer et al. 2005). Such 
heterogeneity in the underlying pathways makes morphological criteria remain 
important in diagnosing apoptosis (Kroemer et al. 2009). 
1.1.4 Interaction between pro- and anti-apoptotic factors determines cell fate 
Interaction between pro- and anti-apoptotic factors determines the progression of cell 
death. Bcl-2 family is a long-studied example and interaction among its members 
regulates mitochondrial outer membrane permeability (MOMP), an important 
checkpoint in apoptosis (Chipuk et al. 2010; Kim et al. 2006). Specifically, anti-
apoptotic members, such as BCL-2, directly bind to pro-apoptotic members, e.g. BAK 
and BAX, to prevent the latter from forming pores within the outer mitochondrial 
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membrane. If the pore forming ability outcoinpetes its antagonizers, soluble proteins 
in the mitochondrial intermembrane space are released into cytosol. Among the 
proteins is cytochrome c that triggers downstream activation of the caspase cascade. 
1.1.5 DNA fragmentation during the execution phase 
During the execution phase, a cell's genome is degraded enzymatically, producing 
two distinct forms of pattern, high molecular weight (HMW) (Cohen et al. 1994; 
Walker et al. 1994) and low molecular weight (LMW) fragments (Wyllie 1980), 
which are thought to appear during early and late stages of execution phase, 
respectively. Among the more than 10 nucleases implicated in apoptotic DNA 
cleavage (Samejima et al. 2005), caspase-activated DNase (CAD) and mitochondrial 
nucleases, apoptosis-inducing factor (AIF) and endonuclease G (EndoG ) �are better 
studied. In non-apoptotic condition, inhibitor of caspase-activated DNase (ICAD) 
binds to, and thus inhibits, CAD. Following apoptotic stimulus, effector caspase 
cleaves ICAD and frees CAD (Sakahira et al. 1998), which then translocates to 
nucleus to fragment DNA during apoptosis (Enari et al. 1998). On the other hand, 
apoptosis-inducing factor (AIF) and endonuclease G (EndoG) are nucleases normally 
residing in mitochondria (Susin et al. 1999; L. Y. Li et al. 2001; Schafer et al. 2004). 
Following MOMP, the nucleases are released into cytosol and nucleus (Amoult et al. 
2003; Munoz-Pinedo et al. 2006). Nevertheless, DNA fragmentation is found not 
required for the induction and progression of apoptotic cell death (Schulze-Osthoff et 
al. 1994). While it is speculated to make a dying cell more manageable to be engulfed 
(Taylor et al. 2008)，the purpose of DNA fragmentation remains to be determined. 
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1.1.6 Current understanding of the point of commitment in apoptosis 
It is generally accepted that pre-execution apoptotic events precedes point of no 
return. In support with this, these events occurring in otherwise healthy, non-apoptotic 
cells, such as in protonophore-induced mitochondrial permeability (Minamikawa et 
al. 1999) or microinjected cytochrome c that mimics cytosolic release of the protein 
(Deshmukli et al. 1998), do not lead to cell death. Also, before the execution phase, 
the anti-apoptotic family can return a cell in initiation phase to original healthy, non-
apoptotic state. For example, (Rosse et al. 1998) show that overexpression of anti-
apoptotic BCL2 survives cells with Bax-induced cytochrome c release; (Martinou et 
al. 1999) demonstrate that, in cells with caspase activity inhibited, mitochondria can 
regain morphology and cytochrome c content after apoptosis-mediated reduction in 
size and release of cytochrome c. Nevertheless, once the execution phase initiates, a 
cell is thought committed to die due to mitochondrial dysfunction (Kroemer et al. 
2005; Chipuk et al. 2005) and the potent proteolytic activity of effector caspase on 
many vital cellular systems (Garcia-Calvo et al. 1999; Taylor et al. 2008; Albeck et al. 
2008). 
1.1.7 Previous studies and hypotheses related to the reversibility of late-state 
apoptosis 
However, accumulating evidences have led to hypotheses suggesting that apoptosis in 
the execution phase does not necessarily lead to irreversible cell death. (Vaughan et 
al. 2002) proposed the "genotoxic effect of surviving apoptosis", suggesting that, 
given the many DNA damaging mechanisms mediated by effector caspase, a cell that 
have survived apoptosis might incur DNA cleavage and potentially carcinogenic 
translocations, contributing to a previously unidentified class of apoptosis-
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d\'srcgulatcd diseases. The proposal was based on four lines of evidence. (1) A study 
using C. elegans mutant without the "eat me" signal (Reddien et al. 2001) finds that, 
during its embryogenesis, some cells normally programmed to die display apoptotic 
morphology (nuclear condensation) and later recover and survive. (2) In an in vitro 
study using population analyses (Sim et al. 2001), the authors observe that some 
anticancer drugs induce a coappearance of apoptotic nucleosomal ladder and cleavage 
within mixed lineage leukemia (MLL) gene, a gene frequently rearranged in therapy-
related acute myeloid leukemia (t-AML). The drugs themselves are genotoxic, 
inducing DNA breaks. To clarify the source of damage, the authors apply inhibitor of 
caspase activity and find that the cleavage within MLL is caspase- dependent, 
suggesting the role of apoptotic nuclease in breaking the gene. Similarly, (Betti et al. 
2001; Stanulla et al. 1997) demonstrated the association of MLL cleavage with 
irradiation and other apoptotic inducers. (3) In two independent studies by (Hammill 
et al. 1999; Geske et al. 2001), the groups study the extemalization of 
phosphatidylserine (PS), one of the earliest apoptotic phenotypes (Kroemer et al. 
2009) indicating a loss of membrane asymmetry maintained in healthy cells 
(Balasubramanian et al. 2003). The altered composition of the outer leaflet of plasma 
membrane acts as an "eat me" signal to instruct neighboring cells or phagocytes to 
engulf the apoptotic cell (Martin et al. 1995; Fadok et al. 1992). The studies 
demonstrate that cells stained with Annexin-V (which binds to externalized PS) 
remain viable and the signal subsides after removal of apoptotic inducer. As PS 
extemalization is found caspase-dependent (Martin et al. 1996) (but remains to be 
demonstrated and was found caspase-independent in other reports, e.g. Zhuang et al. 
(1998), events in the execution phase can potentially be reversible. (4) Effector 
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caspascs arc activated in non-apoptotic context in activated 丁 cells (Alam ct al. 1999), 
suggesting an intrinsic ability for cells to restrict and sustain limited activated caspase. 
Almost a decade later, further evidence came from a study (Albeck et al. 
2008) aiming to quantitatively characterize the dynamics among various factors in 
apoptosis, including MOMP and initiator and effector caspases. Experimental data 
showed that, upon apoptosis induction, a cell population with MOMP disrupted and 
caspase inhibition relieved (by Bcl2 overexpression and XIAP RNAi knockdown, 
respectively) partially cleaved one of the effector caspase substrates, Poly(ADP)-
ribose polymerase (PARP), and, interestingly, a fraction (�45o/o) of the cell population 
was found viable. The authors then established a mathematical model based on the 
biochemistry and the interaction and dynamics among the apoptotic factors, and the 
model described that an individual cell with apoptotic circuitry disrupted could reach 
a state with effector caspase substrates cleaved but not leading to cell demise. Such a 
state was named "partial cell death", similar to the hypothesis by (Vaughan et al. 
2002), suggesting a transient apoptotic state that has a role in generating DNA 
damage that could contribute to cancer. 
Previously, our laboratory demonstrates with single cell imaging that cancer 
cells can regain normal morphology and function after showing apoptotic phenotypes 
that indicate the entry into execution phase (Tang et al. 2009). This phenomenon, 
coined the term reversal of apoptosis, implies an ability of cancer cells to survive 
chemotherapy, which aims to act through apoptosis. In addition, the study also shows 
that nuclear fragmentation, a later event in apoptosis, correlates with cellular ability to 
reverse apoptosis, suggesting this event as the point of no return. 
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1.1.8 Unanswered questions 
However, a comprehensive analysis of apoptotic markers to demonstrate the 
occurrence of late-stage apoptosis before the recovery is lacking. Also, to show that 
the programme to reverse apoptosis is encoded in a cell, minimal manipulation (e.g. 
by genetic means) and study model of normal, non-cancerous cells should be adopted. 
Importantly, the cellular and molecular mechanism driving the recovery process and 
the potential consequence to the survived cell remains to be studied. 
1.2 Hypothesis and objectives, Study models and Significance 
1.2.1 Hypothesis and objectives 
In this study, I hypothesized that (1) normal, non- cancerous mouse cells could 
reverse apoptosis, and (2) the cells that had gone through this process might fail to 
completely repair the genetic damage occurring during apoptosis, producing long 
term cellular consequences. To test these hypotheses, the following objectives were 
established: 
1) To demonstrate the execution phase of apoptosis before cells recover by 
studying morphological and biochemical apoptotic markers with time-lapse 
live cell imaging, fixed- cell fluorescence microscopy and Western blotting. 
2) To demonstrate activation of DNA damaging mechanisms before cells recover 
by studying caspase- dependent and- independent mechanisms and DNA 
strand breaks with Western blotting, immuno-colocalization, and comet assay, 
respectively. 
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3) To measure gcnctic alterations in cell population that survives apoptotic insult 
with micronucleus assay and metaphase spread analyses. 
4) To document the cellular change in cell population that survives apoptotic 
insult by testing its transformation potential with focus formation and 
anchorage independent assays. 
5) To investigate the molecular pathways involved in reversal of apoptosis by 
microarray analysis and inhibition assay with small molecule inhibitors. 
1.2.2 Study models 
The normal, non- cancerous cell models used in the study are mouse primary liver 
cells and the embryonic fibroblast NIH3T3 cell line treated with ethanol and DMSO, 
respectively. The drugs are selected because of being apoptosis-inducing (Hanslick et 
al. 2009; Vondracek et al. 2006; Aita et al. 2005; Castilla et al. 2004), lowly 
mutagenic (Santos 2003; Phillips et al. 2001) (as the genome serves as an important 
apoptotic target for this study), being drugs one is readily exposed to (Santos 2003) 
and other reasons elaborated in the discussion section. 
1.2.3 Significance 
This study will serve as the first experimental evidence suggesting that normal 
mammalian cells have an intrinsic programme to reverse apoptosis, raising the 
possibility that such a programme may operate in vivo. If genetic alterations occur in 
survived cells, this potentially in vivo mechanism may represent a novel endogenous 
pathway to drive carcinogenesis and raise caution over non-mutagenic apoptotic 
stimuli in triggering mutations. Insights in the molecular mechanism behind the 
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rccovcry process may suggest specific intervention that ensures a dying ccll to 




Materials and Methods 
Cell Culture 
Primary liver cells were isolated from BALB/c mice by mechanical and enzymatic 
treatment with collagenase B according to the instruction from manufacturer 
(Worthington, New Jersey, NY, USA). NIH3T3 cells were obtained from American 
Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured in 
DMEM/F-12 (Dulbecco's Modified Eagle medium: Nutrient Mixture F-12) 
supplemented with 10% FBS (Fetal bovine serum), lOOU/mL penicillin and 
100|ig/mL streptomycin (Gibco, Carlsbad, CA, USA), at 3 7 � C under a humidified 
atmosphere of 5% C02/95% air. Before reaching confluence, cells were rid of culture 
medium, rinsed by phosphate-buffered saline (PBS) and incubated with trypsin to 
remove cells from the cultureware surface. A small portion of the cell suspension was 
then neutralized by FBS- containing culture medium and allowed to reattach to a new 
cultureware. This procedure was repeated approximately every three days to maintain 
below 80% confluence. 
Mouse liver cell preparation 
Cells were isolated from the liver of BALB/C mice by a simplified mechanical/ 
enzymatic digestion method. First, the liver was surgically removed from the 
mouse. The tissue was then cut into slices with sterilized scissors and rinsed 
occasionally with ice cold PBS to remove blood released. The tissue slices were 
digested with 0.1% collagenase (Worthington) in DMEM/F12 at 37 for two 
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hours with occasional shaking. Following enzymatic digestion, the resulted 
mixture was centrifuged at low speed to get rid of large fragments. Next, liver 
cells were isolated by centrifuged at lOOg for 3 mins and then cultured in DMEM 
F12 with 20% FBS before subjected to experiment. 
Apoptotic induction 
Cells were seeded onto tissue culture plates for 1- 2 days till reaching 70% confluence 
before experimental treatment. Conditions to induce apoptosis: 4.5% (v/v) ethanol 
(Scharlau, Barcelona, Spain) for 5h and 10% (v/v) cell culture-grade DMSO (Sigma, 
St. Louis, MO, USA) for 20h for primary liver cells and NIH3T3 cells, respectively. 
To remove the apoptotic inducer, drug-containing culture medium was removed and 
the apoptotic cells were washed 3 times with fresh medium followed by culturing in 
condition outlined above. 
Trypan blue exclusion assay 
Cells were washed with PBS once to minimize cell loss following removal of culture 
medium. Trypsinization, as described in Cell Culture section, was then performed and 
neutralized with 10% -FBS fresh medium. The cell suspension was mixed with equal 
volume of trypan blue. Cells stained blue were considered terminal dead. At least a 
total of 100 cells were counted for each replicate and three replicates were performed 
for each condition. 
Time- lapse living cell microscopy 
Liver cells were cultured in C02-independent medium (Invitrogen) on a thenno-cell 
culture FCS2 chamber (Bioptechs, Butler, PA, USA) mounted on an adapter inserted 
23 
on the stage of an inverted fluorescence microscope Cell Observer (Carl Zeiss). 37()C 
was maintained throughout the imaging with no CO2 supply. To induce apoptosis or 
remove the inducer, ethanol containing culture medium (4.5%, v/v), or fresh medium, 
was introduced to the cells through perfusion tubes (Bioptechs) connected to the 
culture chamber. Mitochondria and nuclei staining and fluorescence microscopy were 
performed as discussed below. 
Immunocytochemistry and fluorescence microscopy 
For assessing cell morphology and endocytosis: Mitochondria and nuclei were stained 
in living cells in culture medium with 50nM Mitotracker Red CMXRos (Invitrogen, 
Carlsbad, CA, USA) for 30 mins and 250 ng/mL Hoechst 33342 (Invitrogen, 
Carlsbad, CA, USA) for 10 mins, respectively, for 20 minutes. Endocytosis was 
assessed by incubating live cells in culture medium with green fluorescence emitting 
Quantum Dot from Q t r a c k e r � 525 Cell Labeling Kit (Invitrogen) at 37°C for 60 mins 
as in the product manual. The cells were then fixed with 3.7% (w/v) 
paraformaldehyde in PBS solution for 20 minutes at room temperature before subject 
to fluorescence microscopy. For immunostaining: the fixed cells were permeabilized 
with 0.1% Triton x-100 (v/v) (Sigma) for 10 minutes. Endogenous AIF and EndoG 
were stained, respectively, with anti-AIF antibodies (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) conjugated with green fluorescent Alexa Fluor(g)488 and anti-EndoG 
primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) conjugated 
with red fluorescent Alexa®594 anti-rabbit IgG secondary antibodies. Conjugation 
was performed with Zenon Tricolor Labeling kit (Invitrogen) according to supplier's 
manual. Cell images were captured with a monochromatic CoolSNAP FX camera 
(Roper Scientific, Pleasanton, CA, USA) on an inverted fluorescence microscope Cell 
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Observer (Carl Zeiss, Jena, Germany) using a 63x numerical aperture (NA) 1.4 plan-
Apochroniat objective, and analyzed by using AxioVision 4.2 software (Carl Zeiss). 
Cdl morphology was visualised by differential interference contrast (DlC) 
microscope device (Carl Zeiss). 
Western Blotting 
Approximately 3 jug of protein from total cell lysate per lane was separated on a 12% 
SDS-PAGE gel and transferred onto a Hybond ECL® membrane (Amersham 
Biosciences, Chalfont St Giles, UK). After blocking with 5% milk in PBS(w/v), the 
membrane was incubated overnight at 4 � C with primary antibody detecting target 
protein (1:1000 in PBS), followed by another hour of incubation with the 
corresponding horseradish peroxidase-conjugated secondary antibody (Bio-Rad, 
1:3000 in PBS) at room temperature. Primary antibodies used were: anti-caspase-3, 
anti-PARP (Cell Signaling Technology, Danvers, MA, USA), anti-ICAD (BD 
Pharmingen, BD Biosciences, Le Pont-de-Clax, France), anti-beta- tubulin (Santa 
Cruz), and- p53(Santa Cruz), and and- MDM2(Santa Cruz). The signal from the 
secondary antibody was detected with the ECL Western blotting detection system 
(Amersham Biosciences). 
Single cell gel electrophoresis (comet) assay 
Comet assay was performed using the Trevigen Comet AssayTM kit (Trevigen, 
Gaithersburg, MD, USA) according to manufacturer's instructions. Briefly, harvested 
cells were resuspended in PBS and mixed with low melting point agarose. Then, the 
cells in low melting point agarose were immediately spread onto slides provided by 
the kit and placed at 4° C for the agarose to solidify. Subsequently the gelled cells 
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were immersed in lysis buffer and subject to alkaline electrophoresis using Ready 
Sub-Cell GT Cells (Bio-Rad) on ice with 20 volt and 200 mA for 30 minutes. The 
current was adjusted by the volume of the buffer in the gel tank. DNA was visualized 
by SYBR® Green staining (Trevigen) followed by fluorescence microscopy. In total 
of 300 cells in three replicates were examined for each condition. 
Cytokinesis- block micronucleus assay 
Cells were seeded on cover slip in six-well plate to reach 70% confluence and 
induced to apoptosis as described in previous section. To study genome damage in 
apoptotic cells that recovered and proliferated, the cells were washed and cultured for 
16h in fresh medium that contained cytokinesis- blocking drug cytochalasin B (3 
l^g/ml; Sigma). The cells were then fixed by incubating in methanol/acetic acid (5:1, 
vol/vol) twice for 15 mins followed by overnight fixation. After washed three times 
with phosphate-buffer saline (PBS), the fixed cells were stained for nucleus by 
incubating in Hoechst for 10 min at room temperature. Slides were then prepared as 
described for fluorescence microscopy and observed under 63x objective lens to score 
micronucleus. 
In counting micronuclei in the cytokinesis-blocked cells, the following guidelines, as 
suggested in (Fenech 2007), were followed. Only binucleated cells were scored, so as 
to include only cells that have divided once after addition of cytochalasin B. The two 
main nuclei should have clear boundaries from each other and micronuclei were 
counted only when clear boundary from the main nuclei was observed. The diameter 
of a micronucleus should lie between 1/16 and 1/3 that of the main nuclear diameter. 
Also, triplicates were performed with more than 100 cells for each condition per set. 
26 
Cell transformation assay 
Foais formation assay: Seeded in lOcm^ culture dish (Nunc), NIH3T3 cells were 
induced to apoptosis at 70% confluence and subsequently washed to remove the 
inducer as described in Apoptotic Induction section. Then the cells were maintained 
in culture with changing fresh medium every 3 days. After 3 weeks of culture, 
morphologically transformed foci whose diameter exceeded 0.5 mm were counted. 
The assay was performed three times. From each replicate, at least five transformed 
foci were isolated by picking with sterile pipette tip and were then cultured for soft 
agar assay to validate their transformation potential. Soft agar assay: anchorage-
independent colony formation of NIH3T3 cells was determined as described 
previously (Cifone et al. 1980) with some modifications. 3x10^ cells in 0.3% agarose 
(mixed with 1.5mL completed cell culture medium) were cultured above a layer of 
solidified 0.5% agarose contained in single wells of 6-well culture plate (Nunc). After 
incubation at 37�C under an atmosphere of 5% CO^/95% air for 5 weeks, growing 
colonies were visualized by staining with 0.5 mL of 0.005% crystal violet solution 
(Sigma) for 1 hour before observed under microscope. 
Metaphase phase spread preparation and analysis 
Metaphase chromosome spreads were prepared according to (MacLeod et al. 2007) 
with modifications. Briefly, cells were arrested at metaphase by adding colchicine at a 
final concentration of lug/mL into growing culture for 8 h. The arrested cells were 
then collected with trypsinization followed by spinning at 400g for 5 min. After 
discarding the supernatant, the cell pellet was loosened by gentle flicking in residual 
medium. To swell the mitotic cells, the cell suspension was incubated at 3 7 � C in 
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hypotonic bulTcr, potassium chloride (5.59g/L) and sodium citratc (9.0g/L) in 1:1 
(vol/vol), for 8 and 15 min, for N1H3T3 and primary liver cells, respectively. The 
cells were then pelleted at 400g for 5 min to remove the hypotonic buffer. Next, the 
cells were fixed by gently adding freshly prepared ice-cold fixative (methanol and 
acetic acid, 3:1 vol/vol) to the pellet while agitating the centrifuge tube the whole 
time, so as to prevent cell clumps and encourage mixing. The fixative was changed 
once and then the cells were fixed overnight at 4 Next, after concentrated in a 
volume with optimal cell concentration, the cell suspension was dropped from height 
onto a chilly pre-cleaned SUPERFROST® PLUS microscopic slide (Thermo 
Scientific) slightly-sloped on a freezer block to spread well the metaphases. Then the 
slides were breathed on to enhance spreading and were mounted after dried. The 
metaphase chromosomes of mitotic cells were identified and captured by automated 
cytogenetic scanner workstation (MetaSystems) for analysis. Only metaphases of 
distinctly separated chromosomes and of chromosome spreading pattern from one 
nucleus, to avoid overlapped metaphases, were counted. Chromosomes arranged in 
radial structure were counted as chromosomal abnormality. In total, three replicates, 
each with more than 100 metaphases, were performed. 
Microarray data analysis 
Primary mouse liver cells of conditions: untreated, treated (RO) (as in Apoptotic 
Induction section) and three points, 3 h (R3), 6h (R6) and 24h (R24), after removal of 
inducer, were prepared with three replicates for each condition. RNA was extracted 
with RNeasy Mini Kit (Qiagen, Cologne, Germany). After assessing the quality with 
gel electrophoresis and optical density measurement, RNA samples were shipped for 
microarray analysis on the platform MouseWG-6 V2.0 expression beadchip (Illumina, 
28 
Inc) with Agilent Gene expression DNA microarray services, including target 
labeling, hybridization, signal detection and basic data analysis (i.e. image processing, 
normalization and data output as fold change comparison against the treated 
condition). Filtering for genes with desired features was performed with a visual 
programming tool Orange 2.0b (available for download at orange.biolab.si). A list of 
genes putatively important for reversal of apoptosis was compiled by merging the 
transiently upregulated genes (defined by criteria: R3 vs RO, OR R6 vs RO, linear fold 
change > 1.5 fold, p value<0.05, AND NOT R24 vs RO >1.5) and transiently 
downregulated genes (R3 vs RO, OR R6 vs RO, linear fold change < -1.5 fold, p 
value<0.05 AND NOT R24 vs RO < -1.5). The list generated was input to a web-
based gene ontology analysis tool Gene Ontology Enrichment Analysis Software 
Toolkit (GOEAST) (Zheng et al. 2008). Parameters selected were statistical test 





In the experiments healthy cells (Untreated) were treated with apoptotic inducer at a 
condition that induced the majority of them to apoptosis (Treated). Inducer-containing 
culture medium was then removed from the treated cells and replaced by fresh 
medium to allow cells to recover (Washed). 
3.1 Dying cells reversed execution stage of apoptosis after removal of apoptotic 
stimuli 
The first task was to show that the drugs, ethanol and DMSO, were able to drive 
primary liver and NIH3T3 cells, respectively, to terminal cell death, as indicated by 
loss of plasma membrane integrity (defined in Kroemer et al. (2009)). After 
incubation with the drugs (4.5% ethanol for 5h and 10% DMSO for 24h, which were 
conditions consistently used in the following experiments unless otherwise stated), the 
cells rounded and reduced in cytoplasmic volume (Figure lA, B), characters of 
apoptosis (Kroemer et al. 2009). After further incubation for additional 24h, majority 
of cells ( -90 % for both models) lost membrane integrity (Figure IC) and became 
permeable to vital stain trypan blue, which intact membrane of live cells can exclude. 
However, after the drug-containing culture medium was removed in the midst of 
induction (ethanol at 5 h and DMSO at 24 h) and replaced with fresh medium for 24h, 
morphology of the cells became non-apoptotic (Figure 1 A, B). 
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Figure 1 
Morphology and plasma membrane integrity of the primary liver cells and 
NIH3T3 cells in apoptotic inductions and after reversal of apoptosis. 
A) and B) Phase contrast images of the untreated (Untreated), the apoptosis-induced 
(Treated), the washed (Washed), and the continuously induced (Continuous) liver (A) 
and NIH3T3 (B) cells on culture plate and in trypan blue stain after harvested by 
trypsinization. Apoptotic induction of liver: 4.5% ethanol in culture medium for 5 
32 
hours (Treated), and 36 hours (Continuous); NIH3T3: 10% DMSO in culture medium 
tor 20 hours (Treated), and 48 hours (Continuous). Scale bar, 100 ji m. 
C) Percentage of the untreated, the treated, the washed, and the continuously induced 
liver cells and N1H3T3 cells that displayed trypan blue stain, ns: P>0.05; * P<0.05; 
**P<0.01. n=3. Error bars denote s.d. 
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Next, to confirm the occurrencc of apoptosis at the treated condition and the 
later rccovcry 24h after removal of inducer, morphological and biochcmical markers 
of apoptosis were evaluated. Upon treatment, majority of the liver and NIH3T3 cells 
exhibited apoptotic phenotypes. The cells rounded and reduced cytoplasmic volume 
(cell shrinkage), the nuclei reduced in size (nucleus condensation) and their 
mitochondria changed from network-like into a diffused form (mitochondria 
fragmentation) (Figure 2A, B). Cell shrinkage and nuclear condensation are 
considered to result from the activity of effector caspase (Taylor et al. 2008); whereas 
mitochondrial fragmentation is thought to coincide the release of pro-apoptotic factors 
(such as cytochrome c and others) in mitochondrial intermembrane (Amoult 2007) 
and is a phenotype further reinforced by caspase activity (Amoult et al. 2003). To 
sum up, these three phenotypes suggested majority of the cells had entered the 
execution phase of apoptosis (Kroemer et al. 2009). In support with this, Western 
blotting demonstrated activation of caspase-3 in the treated cells (Figure 2C), which is 
an effector caspase that is active when cleaved (Bose et al. 2003) and is responsible 
for the majority of cellular demolition (Slee et al. 2001; Luthi et al. 2007). After 
replacing the drug-containing medium with fresh medium for 24h, the percentage of 
cells with the morphological phenotypes significantly decreased to the level slightly 
higher than the untreated condition, with the cells well-spread, their mitochondria 
returning tubular and nuclei regaining in size (Figure 2A, B). Also, the inactive 
proenzyme form of caspase-3 predominated in the washed condition (Figure 2C). 
Altogether the data showed that the two models used in this study, primary liver and 
NIH3T3 cells treated with ethanol and DMSO, respectively, could reverse the 
apoptotic phenotypes, as seen previously in the cancer cell lines 
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Figure 2 
Reversal of apoptosis in mouse primary liver cells and mouse embryonic 
fibroblast NIH3T3 cells. 
A) Fluorescence and DIG microscopy of healthy, untreated liver and NIH3T3 cells, 
the cells were exposed to apoptotic inducers (Liver cells: 4.5% ethanol for 5 hours; 
NIH3T3 cells: 10% DMSO for 20 hours) (Treated), and the induced cells were 
washed to remove apoptotic inducers and further cultured for 24 hours (Washed). 
Merged images: Mitotracker stains for mitochondria (red), Hoechst (DAPI) for 
nucleus (blue), Quantum dots (Qdot) taken up by endocytosis (green). 
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B) Percentage of the untreated, the treated and the washed liver cclls and Nil 13 13 
L�dls that displayed mitochondrial fragmentation (Mito fragment), nuclear 
condensation (Nuc condcnse), cell shrinkage (Cell shrink) and uptake of Quantum 
dots by endocytosis (Endocytosis). ns: P>0.01; * P<0.01. n=3. Error bars denote s.d. 
C) Western blot analysis on the total cell lysate of the untreated, the treated, and the 
washed liver cells and NIH3T3 cells for the protein level of caspase-3 (Casp). c, 
cleaved form. 
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(Tang ct al. 2009). The survival of the cells was further validated by their resuming 
cndocytosis, as indicated by uptake of peptide-tagged green fluorescent quantum dots 
into the cytoplasm of the "washed" cells (Figure 2A, B, C). 
To further demonstrate that same cells that have shown the apoptotic 
phenotypes can reverse apoptotic process, time-lapse living cell imaging was 
performed on the liver cell model (cytotoxicity of the culture condition in the imaging 
on NIH3T3 cells prohibits the model for this experiment). As shown in Figure 3A, 
treated with 4.5% of ethanol for 2.5h, majority of the cells were apoptotic, with cell 
shrinkage, mitochondrial fragmentation and nuclear condensation (The earlier 
emergence of apoptotic phenotypes in this time-lapse fluorescence imaging could be 
due to phototoxicity from the imaging process and the toxicity of the mitochondrial 
and the nuclear stains). After replenished with fresh medium, none of the cells were 
dislodged (66 cells in the treated condition and 70 cells at 4h 50min, which could be 
due to cell migration) and all regained non-apoptotic morphology (e.g. the cells 
marked with arrows). In Figure 3B, a single liver cell was tracked at a higher 
magnification and, in addition to the phenotypes described above, the cell survived 
membrane blebbing, which results from caspase-3 activity (Coleman et al. 2001; 
Sebbagh et al. 2001). In the experiments, removal of apoptotic inducers was sufficient 
to promote reversal of apoptosis, indicating that reversal of apoptosis is an intrinsic 
mechanism allowing cells to recover from execution phase. 
3.2 Dying cells reversed apoptosis after DNA damage 
A cell's genome is fragmented by mechanisms mediated by effector caspase and 
mitochondria during the execution phase of apoptosis (Samejima et al. 2005; Nagata 






Demonstration of reversal of ethanol-induced apoptosis with time-lapse 
microscopy in mouse primary liver cells 
A) and B) Time-lapse living cell image of the same liver cell before ethanol induction 
(Untreated), induced by 4.5% of ethanol in culture medium for � 2 . 5 hours (Treated), 
and then washed and further cultured with fresh medium (Washed). Arrows of the 
same colors track the same cells. Merged images: mitochondria (red) and nuclei (blue) 
were visualized by fluorescence and cell morphology by DIC microscopy. Time is 
shown in h: min. Scale bars, 50 / / m in A; 10 ju m in B. 
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Figure 4 
Translocation of mitochondrial nucleases in the dying cells before reversal of 
apoptosis 
A) Fluorescence microscopy for the subcellular localization of AIF (green), EndoG 
(red) and nucleus (blue) in the untreated, the treated and the washed NIH3T3 cells. 
Quantification of the corresponding fluorescence signals of AIF, EndoG and nucleus 
along the dotted line as indicated at their respective images. Scale bar, 10 f im. 
B) Percentage of the untreated, the treated and the washed liver cells and NIH3T3 
cells that displayed nuclear accumulation of AIF and EndoG. ns: P>0.01; * P<0.01. 
n=3. Error bars denote s.d. 
40 
A J" 。凌 J" 
A 务 , 务 , 
— — 1 ^ � PARP 
MMP 一 cPARP 
WmtB � • � — ICAD 
• � cICAD 
, ； 
Liver cells NIH3T3 cells 
B 
Untreated Treated Washed mmm 
C • Liver cells • NIH3T3 cells 
一 100 
B 80 • 
1 60 _ • 
8 40 _ _ J _ • 
I H a, 
Untreated Treated Washed 
Figure 5 
Caspase-mediated deactivation of DNA protection mechanisms and DNA 
damage in the dying cells before reversal of apoptosis 
A) Western blot analysis on the total cell lysate of the untreated, the treated, and the 
washed liver cells and NIH3T3 cells for the protein level of PARP and ICAD. c, 
cleaved form. 
B) Fluorescence microscopy for the DNA stain of the untreated, the treated and the 
washed NIH3T3 cells subjected to comet assay. Damaged DNA ran out of the nuclear 
envelop after electrophoresis, and displayed comet tails as indicated by arrow for one 
of the treated cells. Intact DNA immigrated, remained in nuclear envelops as in the 
untreated cells. Scale bar, 100 " m . 41 
C) Pcrccntagc of the untreated, the treated and the washed liver cclls and NllIB'! 3 
cells that displayed comet tail, ns: P>0.01; **P<0.01. n=3. Error bars denote s.d. 
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To detect at single cell level actual DNA damage in the dying cclls before 
reversing apoptosis, single- cell gel electrophoresis (comet) assay was adopted (Olive 
et al. 2006). In the assay, a voltage difference is applied across permeabilized single 
cells suspended in soft agar. Fragmented DNA, either by single- or double- strand 
breaks, migrates out of nuclear envelope and is stained as a comet tail (indicated with 
a white arrow in figure 5B) under microscopy, contrasting bulky unfragmented DNA 
that remains stationary. In the experiment, a majority of treated cells displayed comet 
tail and, after removal of apoptotic inducers, the percentage of cells that showed 
comet tail significantly reduced (Figure 5B, C). In consistent with the activation of 
DNA damaging mechanisms (Figures 4, 5A), the data suggested that the genomes of 
the dying cells were once damaged. 
3.3 Genetic alterations and transformation occurred after reversal of apoptosis 
Unrepaired DNA damage results in genetic alterations. A micronucleus forms 
(examples shown in figure 6A, marked with white arrows) at the end of nuclear 
division as nuclear envelop wraps around whole chromosomes or fragmented 
chromosomes that fail to migrate with the rest of chromosomes, which on the other 
hand forms the main nucleus. Thus, micronucleus formation serves as a biomarker for 
genotoxic events. Measured by the cytokinesis- block micronucleus assay (described 
in Fenech (2007)), the cells that have survived apoptotic insults exhibited an increase 
in the frequency of binucleated cells that were micronucleated (Figure 6A, B). The 
data suggested that the dividing population, as manifested as binucleated, suffered 
from a loss of genetic content, consistent with the transiently activated DNA 
damaging mechanisms and impaired DNA repairing during apoptosis; and passed this 
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Enhanced micronucleus formation after reversal of apoptosis 
A) Fluorescence microscopy on nuclear morphology of the untreated (i) and the 
washed (ii-iv) binucleated NIH3T3 cells 16 hours after removal of apoptotic inducer. 
Arrows indicate micronuclei in the washed cells. Scale bar, 10 / /m. 
B) Percentage of the untreated and the washed binucleated liver cells and NIH3T3 
cells that displayed micronuclei. ns:户〉0.05; * 尸<0.05; **P<0.01. n=3. Error bars 
denote s.d. 
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The evidence that the daughter cells inherited genomes different from the 
mother cells that had survived apoptosis led us to further characterize the gcnctic 
changes from reversal of apoptosis. Metaphase preparation (as described in Padilla-
Nash et al. (2006) and MacLeod et al. (2007)) from cells three days after removal of 
apoptotic inducers (reversed cells) found distorted chromosome profiles in the 
reversed cells comparing to the cells without apoptotic treatment (Figure 7A). In the 
liver cell model, after apoptotic treatment, the percentage of cells within the modal 
range dropped markedly and cells with a higher or lower number of chromosomes 
were more abundant; whereas in the NIH3T3 model, the modal range shifted and, 
similarly, with greater number of cells outside the modal range. Interestingly, among 
the metaphase spreads of the reversed cells, some chromosomes were found arranged 
in radial configuration with arms of different chromosomes associated (Figure 7B). 
This type of chromosomal abnormality is an indicator of chromatid exchange 
(reviewed in Bryant (2007)). In both of the cell models, cells after apoptotic treatment 
showed enhanced frequency of such chromosomal abnormality (Figure 7C). 
Genetic alterations promote phenotypic diversity in the process of 
carcinogenesis (Stratton et al. 2009). Transformation assays that examine phenotypic 
changes associated with carcinogenesis serve as a suitable tool and the NIH3T3 cell is 
a commonly used model due to its inclination to transformation (Rubin et al. 1989). 
As expected, clumps of overlying cells, which indicates loss of contact inhibition, 
were observed at a higher frequency in NIH3T3 cells that had experienced apoptotic 
insult (Figure 8A, C). To further confirm the transformed phenotype of those 
overlying cells, they were sterilely picked and cultured. They were then subject to 
anchorage-independent assay, in which only cells that acquire the anchorage 
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Figure 7 
Genetic alterations after reversal of apoptosis 
A) Percentage of the untreated and the reversed liver and NIH3T3 cells displaying the 
indicated number of chromosomes in metaphase spreads. 
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B) Image of metaphase spreads of the untreated NIH3T3 ccll (Untreated) and the cell 
3 days after reversal of the DMSO-induccd apoptosis (Reversed). Enlarged images 
tVoni the corresponding dotted boxes. The number of metaphase chromosomes is 
indicated at the corresponding images. 
C) Percentage of the untreated and the washed liver and NIH3T3 cells displaying 
abnormality in chromosomal configuration. 
ns: P>0.05; * P<0.05; **P<0.01. n=3. Error bars denote s.d. 
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Figure 8 
Oncogenic transformation after reversal of apoptosis 
A) Image of the untreated NIH3T3 cells and the foci from the cells after reversal of 
apoptosis (Reversed) after 3 weeks of culture. Scale bars: 50 “ m. 
B) Image of crystal violet stained colonies in soft agar of the untreated and the 
reversed NIH3T3 cells from the foci at the fifth week of culture Enlarged images 
from the corresponding dotted boxes. Scale bars of enlarged image, 400 “ m. 
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〔、）Number of foci of the untreated and the reversed N1H3 13 ccll cultures at the third 
week of culture. 
L)) Number of colonies formed in soft agar of the untreated and the reversed N1H3T3 
cells after 5 weeks of culture, ns, P>0.05; *P<0.05. n=3. Error bars denote s.d. 
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independence can grow suspended as a colony in soft agar (Figure 8B). Eliminating 
the foci that failed to grow in soft agar, transformation potential of the NIH3T3 cells 
that have survived apoptotic treatment was calculated and was significantly higher 
than the untreated cells (Figure 8D). 
3.4 Investigating molecular mechanism driving reversal of apoptosis 
3.4.1 Preparation and characterization of samples for microarray 
The primary mouse liver cell model was used to further characterize the molecular 
mechanism driving reversal of apoptosis. To thoroughly document the molecular 
changes of the process, a whole genome expression profiling experiment was 
conducted on five time points, before induction (Untreated), at the end of apoptotic 
induction (RO), three hours (R3), six hours (R6) and 24 hours (R24) after removal of 
inducer. First, the samples in parallel to those collected for RNA analysis were 
characterized by phase contrast microscopy and Western blotting for caspase-3 and its 
substrate PARP. After removal of ethanol-containing medium, at the h and h, 
cells started to regain non-apoptotic morphology, increasing its cytoplasmic volume 
and spreading out on the culture plate (Figure 9A); at the same time, the cells showed 
markedly reduced PARP cleavage and barely detected cleaved caspase- 3 (Figure 
9B), At the 24th h, the cells appeared non-apoptotic (Figure 9A) with residual cleaved 
PARP and undetectable cleaved caspase-3 (Figure 9B). Therefore, I reason that at the 
time points R3 and R6 cells were undergoing biological processes integral in the 
reversal of apoptosis. 
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Figure 9 
Morphological and biochemical changes of the reversal of apoptosis in mouse 
liver cells across time 
A) Phase contrast microscopy of the mouse liver cells that were not treated 
(Untreated), that were treated with 4.5% ethanol for 5h (RO), that were replenished 
with fresh medium after ethanol treatment for 3 h (R3), that for 6h (R6) and that for 
24h (R24). Scale bar, 50 fim. 
B) Western blotting for caspase-3 (Casp3) and PARP on the total cell lysates 
collected at time points as indicated, c, cleaved form. RNA lysates were collected in 
parallel from the same 6-well dishes for microarray analysis. 
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3.4.2 Gene ontology enrichment analysis of the expression profile during reversal 
of apoptosis 
Based on the previous data (Figure 9), genes that showed transient differential 
expression at time points R3 and R6 could represent a pool of genes that are 
putatively significant in the reversal of apoptosis. By filtering for either transiently 
upregulated or downregulated transcripts according to the scheme in Figure 10, a list 
of 857 transcripts (527 transiently up and 330 transiently down) were obtained from 
the 30,774 transcripts on the mouse whole genome platform. Then, the list was 
subject to gene ontology analysis by the Gene Ontology Enrichment Software Toolkit 
(GOEAST) (Zheng et al. 2008), which outputs graphical representation of enriched 
Gene Ontology (GO) terms in its original hierarchical tree structure. Since a gene 
belonging to a particular GO term is also a member to all its parent terms, visualizing 
the positional relationships among the GO terms allows one to trace the origin of 
enrichment of a GO term higher in hierarchy to more specific, at a lower position, GO 
terms, giving a more coherent picture. 
The GO enrichment analysis showed that the cells at R3, R6 were under stress, 
showing differentially expressed genes enriched in "responses to DNA damage", "ER 
(endoplasmic reticulum) overload response，，and "response to unfolded protein" 
(Figure 11 A). Related to these processes, "DNA metabolic process" was enriched 
(Figure IIB), under which were enriched terms including "DNA-dependent DNA 
replication" (Figure I IB) and "DNA repair" ("base-excision repair, gap filling" and 
"double-strand break repair") (Figure IIC); “Protein metabolic process" and “protein 
catabolic process" were also enriched (Figure IID). Notably, tracing down the tree, 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1 1 
Cene ontology enrichment analysis of the differentially expressed genes shortly 
after removal of apoptotic inducer with GOEAST 
As detailed in the main text, genes that either differentially expressed at R3 or R6 
(comparing to RO) were used for analysis with the web-based tool GOEAST, which 
produced this graphical output. GO terms are arranged as in the hierarchy of GO 
database. Significantly enriched GO terms are in yellow box. Intensity of the colour is 
positively correlated to significance of enrichment (white indicates not significantly 
enriched terms). Red arrows connect significantly enriched terms, solid back arrows 
between one enriched and the other not, and dashed black arrows between two not 
significantly enriched terms. GO terms discussed in the main text are magnified 
showing processes related A) stress responses, B) DNA metabolic processes, C) DNA 
repair mechanisms, D) protein metabolism, and E) ubiquitin- proteosome degradation. 
55 
same 32 transcripts under the term "ubiquitin-dependent protein catabolic proccss" 
(Figure 1 IE), suggesting an important role of ubiquitin- degradation system in protein 
catabolism at these two time points. Taken together, the cells performing the recovery 
process were under DNA damage and unfolded protein stresses and undergoing 
intense DNA and protein metabolism. 
3.4.3 Interfering stress response or anti-apoptotic factors during the reversal of 
apoptosis drove cells to terminal death 
These stressful conditions suggest that interfering the cell's mechanisms to withstand 
the stresses may drive the reversing cells to die. The p53-MDM2 interaction is an 
important DNA damage signalling mechanism (reviewed in Meek (2004); Bose et al. 
(2007)). Without DNA damage, p53 activity is maintained low by ubiquitin mediated 
degradation and functional inhibition by MDM2 (Kubbutat et al. 1997). Following 
DNA damage, p53 is stabilized concurrent with MDM2 degradation (Stommel et al. 
2004; Inuzuka et al. 2010). Similarly in the mouse liver cell model, p53 was stabilized 
together with disappearance of MDM2 at the treated condition (Figure 12). Removal 
of ethanol led to reduced p53 accompanied by increase of MDM2 (Figure 12). As 
elevated p53 induces apoptosis (Laptenko et al. 2006), this suggests that MDM2 may 
allow the dying cells to recover by suppressing p53. In addition, manipulating the 
unfolded protein response and ER stress may represent the second candidate to 
perturb reversal of apoptosis. When unfolded proteins accumulate in ER causing ER 
stress, cells initiate responses including increasing protein folding capacity (Schroder 
et al. 2005) and degrading misfolded proteins by ubiquitin proteosome system 
(McClellan et al. 2005). HSP90 plays an important role in response to these stresses, 
acting as a chaperone in ER facilitating protein folding 
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Figure 12 
Accumulation of MDM2 accompanied by reduced p53 after removal of ethanol 
in mouse liver cells 
Western blotting on total cell lysate of cells before treatment (Untreated), at the end of 
apoptotic treatment (Treated) and 24h after removal of treatment (Washed). Beta-
tubulin acts as a loading control. 
57 
(Wang ct al. 2006; Argon et al. 1999) to alleviate ER stress, and targeting terminal 
mis folded proteins to degradation (McClellan et al. 2005). Inhibiting HSP90 may 
result in terminal death of the reversing cells by downtuning capacity to withstand ER 
stress. In addition, XIAP and BCL2 are the other two candidates to test, given the 
former's ability to suppressed cleaved caspase 3 activity and proposed role to survive 
effector caspase-activated cell state (Albeck et al. 2008) and the latter as a prominent 
determinant in apoptotic checkpoint (Danial et al. 2004). 
To test the role of the proteins (MDM2, HSP90，XIAP and BCL2) in reversal of 
apoptosis, small molecule inhibitors specifically inhibiting their functions were 
applied immediately (correspondingly: Nutlin-3, 10|LIM; 17-allylaminogeldanamycin, 
0.5|LIM; Embelin, 2 0 f i M ; A B T 263, 1|LIM) after removal of the apoptotic inducer by 
mixing the drugs in the fresh medium to recover the cells. As expected, the cells 
appeared round and detached (Figure 13 A) and around 60% of cells were permeable 
to the vital dye trypan blue (Figure 13B). A Western blotting showed that the death 
was caspase-3-medated (Figure 14). 
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Figure 13 
Suppression of BCL2, XIAP, MDM2 and HSP90 led the washed cells to terminal 
cell death 
A) Phase contrast images of the untreated, or the washed liver cells, with or without 
24-hour exposure of inhibitor after removal of ethanol. Inhibitors used, against: BCL2 
(ABT 263, l|iM), XIAP (Embelin, 20^M), MDM2 (Nutlin-3, 10|.iM) and HSP90 (17-
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allylaniinogcldanamycin, ().5|liM). Washed, or Untreated, means experiencing 
apoptotic induction, or not, before exposure to inhibitor. The washed cclls were 
exposed to the inhibitors as indicated and cultured for 24h after 4.5% 5-h ethanol 
treatment. Scale bar: 50 (i m. 
B) Percentage of the untreated and the washed liver cells, with or without 24-hour 
exposure to inhibitor as indicated, displaying full plasma membrane permeability in 
trypan blue exclusion assay. Drug dosage and duration were identical as in (A), ns: 
P>0.05; * P<0.05. n=3. Error bars denote s.d. 
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Figure 14 
Persistence of activated caspase-3 in the washed liver cells with 24-hour exposure 
of inhibitors against BCL2, XIAP, MDM2 and HSP90 
Western blotting on the total cell lysate of the untreated, or the washed liver cells, 
with or without 24-hour exposure to inhibitor as indicated. Washed, or Untreated, 
means experiencing apoptotic induction, or not, before exposure to inhibitor. The 
washed cells were exposed to the inhibitors as indicated and cultured for 24h after 
4.50/0 5-h ethanol treatment. A sample from cells with ethanol treated was also 
included as Treated. Drug dosage and duration were identical as in Figure 13 (A). 




4.1 Reversal of apoptosis in ‘‘normal cells" was observed 
The process of reversing apoptosis so far has not been widely documented. One of the 
possible reasons is the temporally heterogeneous response to apoptotic inducer 
(Spencer et al. 2009), which poses problems to population methods that tend to mask 
important observations occurring in a fraction of cells. The choice of inducer in this 
thesis has several advantages that allow reversal of apoptosis to be observed. The 
concentrations of drugs used are 10^- to 10^ -fold higher (10% DMSO二 1.41 M; 
4.5%, 5% ethanol= 0,770, 0.856 M), comparing to the millimolar, or micromolar, 
range of concentration commonly used. The temporal heterogeneity in response partly 
stems from the stochasticity in the biochemical reactions (Volfson et al. 2006; 
Spencer et al. 2009), which is prominent in reactions where their constituents are of 
low number (Raser et al. 2005). For example, in a study that investigates the origin of 
gene expression heterogeneity within a genetically identical population of yeast 
(Volfson et al. 2006)，increasing the concentration (from 0.1% to 2%) of galactose, 
which induce GALl promoter-driven yEGFP expression, reduces the variation of the 
fluorescent signals within the population (from variation coefficients of 0.6 to -0.3). 
In molecular level, it can be understood as that each cell is in more frequent contact 
with the drug molecules (in other words, exposed to similar level of drugs) due to the 
high total number present in culture medium. This may explain, in our case, how 
individual cells proceed with the apoptotic pathway at similar dynamics (as in the 
imaging in Figure 3A), thus allowing the use of population methods. Besides, the 
drugs are not known to irreversibly bind to cellular components and, as a result, their 
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0fleets on pro-apoptotic signaling can be removed readily together with the culturc 
medium. 
By using a combination of morphological (Figure 2A, B), biochemical 
(Figures 2C, 5A, the latter showed activity of caspase 3), and molecular (Figure 4A, 
B) markers, apoptosis mediated by effector caspase (Figures 2, 5A) and mitochondria 
(Figures 2A, B, 4A, B) was shown to occur in majority of cells in the mouse primary 
liver cell and NIH3T3 model. Supplemented with live cell imaging that traced 
recovery of the same cells (Figure 3), the large portion of cells that returned to non-
apoptotic state after removal of inducer indicated that majority of the survived cells 
had gone through the process of reversal of apoptosis, thus suitable for further 
characterization of DNA damage. 
4.2 Cells surviving apoptosis had their genomes damaged and altered 
When the cells were treated, caspase- and mitochondria- mediated DNA damaging 
mechanisms are activated (Figures 4, 5A). CAD, EndoG and AIF were reported to 
induce HMW fragments (Susin et al. 1999; Zhang et al. 1998; Schafer et al. 2004). 
This type of DNA damage produced is in agreement with DNA strand breaks 
observed in comet assay (Figure 5B). The consequence of DNA fragmentation 
depends on whether, and how, they are repaired. However, DNA repair machinery 
was transiently suppressed in the treated cells, as evidenced by the marked cleavage 
of PARP (Figure 5A). PARP binds to DNA breakpoints and signals repairing 
mechanism by catalyzing its own poly-(ADP-ribosyl)ation (Olivera et al. 1982; 
Mortusewicz et al. 2007). Loss of function of PARP itself is also known to cause 
genomic instability (Trucco et al. 1998; Wang et al. 1997). Therefore, it is plausible 
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that DNA repairing is inefficient or disrupted temporarily although DNA damaging 
mechanisms were no longer inactive after removal of inducer ("Washed" in Figures 
4A and 5A). 
Evidence supported that, in a portion of the cells, apoptosis-mediated DNA 
fragmentation were unrepaired, or misrepaired, as shown in the micronucleus assay 
(Figure 6A) and radial configuration of chromosome (Figure 7B). When unrepaired, a 
DNA fragment is not able to properly segregate due to being separated from 
centromeric region and, thus, fails to be included in the formation of nuclear envelope 
during nuclear division of mitosis, as a result, manifested as a micronucleus (Figure 
6A). The radial structures found in the metaphase spread analysis (Figure 7B) 
demonstrated the cases that the fragmentation was misrepaired. Radial structures 
originate from chromatid exchange (reviewed in Bryant (2007)), which are rarely 
observed in mitosis (German 1964). They are considered to be formed when two 
broken chromatids of distinct chromosomes exchange the detached fragments, and the 
detached (now joined to a different chromosome) remain bound to their sister 
chromatids. Being a type of chromosomal-level alterations, radial structure probably 
forms from HMW fragments and, in support with this, HMW fragments were shown 
to appear relatively early in execution phase (Cohen et al. 1994). Depending on 
whether the two broken chromatids involved are homologous or not, the radial 
structure when resolved may result in loss of heterogeneity or translocation, 
respectively (reviewed in Ferguson et al. (2001)). Through these two mechanisms, 
DNA damages mediated by apoptosis can translate into persistent genetic alterations. 
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4.3 I raiisforIllation occurred after reversal of apoptosis 
Among the cells that have survived apoptosis, there was a significant portion that had 
acquired transformation phenotypes (Figure 8). Acquisition of multiple characters that 
confer selective advantage for growth (e.g. loss of contact inhibition and anchorage 
independent growth) fuels cancer progression (Hanahan 2000; Hanahan et al. 2011). 
In fact, the transformation phenotypes assayed in this study correlate well with the in 
vivo tumorigenicity (Cifone et al. 1980; Freedman et al. 1974), suggesting an 
oncogenic role of reversal of apoptosis. 
To further test the hypothesis of enhanced in vivo tumorigenicity, development 
of a traceable marker for the cells that have reversed apoptosis would be important, as 
discussed in a later section. Also, identifying the genetic alterations responsible for 
the transformation would provide more insights on the mechanism of reversal of 
apoptosis in causing transformation. However, it is conceivable that the alteration 
sites disperse in the genome due to the genome-wide action by multiple apoptotic 
nucleases (e.g. Widlak et al. (2000); Liu et al. (2003)). Also, transformation 
phenotypes are a concerted result of multiple cellular pathways (Mori et al. 2009) and 
oncogenic mutations are numerous (reviewed in Greenman et al. (2007)). Hence, only 
a large- scale analysis for locations of breakpoints found in the survived cells will 
establish a role of reversal of apoptosis in causing transformation. 
4.4 Investigating molecular mechanism driving reversal of apoptosis 
After removal of apoptotic inducer, dying cells undergo dramatic changes, evidenced 
morphologically and biochemically from time points RO to R24 (Figure 9). The first 
and imminent task would be to halt the ongoing apoptotic pathway. The mechanism 
to suppress progression of apoptosis likely shares similarity with the mechanism to 
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inhibit apoptosis from initiation. Trypan blue assay with specific inhibition implicated 
an important role of XIAP and BCL2, which likely contribute by suppressing the 
activity of cleaved caspase-3 (Huang et al. 2001) and ubiquitinating the protein for 
degradation (Suzuki et al. 2001), and restoring mitochondrial outer membrane 
integrity (Chipuk et al. 2010), respectively. Interestingly, these two genes showed no 
significant differential expression at R3 and R6, comparing to RO (treated). It is 
possible that its ability to survive apoptotic cells stemmed from existing pool of the 
proteins or three hours were too long to detect expression changes in molecular 
factors that acted to stop ongoing apoptotic signal. 
Even if the dying cells succeeded in arresting apoptotic progression, they needed to 
repair the apoptosis-mediated damage that would otherwise cause cell death. The 
enriched GO terms ‘‘ base excision repair, gap filling" and "double- strand break 
repair" (Figure I IC) suggest that the cells at time points R3 and R6 were repairing 
DNA damage, probably resulted from initiated apoptosis (Figures 4 and 5). Small 
molecule inhibitor experiments (Figures 13 and 14) implicated a role of MDM2 in the 
reversal of apoptosis and that might relate to DNA repair since the protein is a 
negative regulator of p53 (Stommel et al. 2004; Inuzuka et al. 2010), an important 
DNA damage sensing molecule (Meek 2004). Three hours after removal of apoptotic 
stimulus (R3), mdm2 expression peaked, 9.3 folds higher comparing to RO (and 
gradually dropped to 2.9 at 24出 h after removing inducer). Such a high level o f m d m 2 
expression would suppress p53's activity, given the MDM2 mediated degradation and 
inhibitory effect on p53 (Kubbutat et al. 1997). This would avoid a high level of p53 
that can lead to apoptosis (Laptenko et al. 2006) and, as a result, survive the DNA 
damaged- cells for repair. To support this statement, MDM2 inhibitor applied at a 
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dose that did not inducc apoptosis in healthy cells cause the cells that would otherwise 
repair DNA damage (Figure 1IC) to death (Figures 13 and 14). In other words, 
MDM2 inhibitor sensitized the reversing cells to the not yet repaired DNA damage, 
leading to cell death. MDM2 might also play an even more important role in reversing 
apoptosis. Although MDM2 negatively regulates p53, the latter, being a transcription 
factor, transactivates the expression of mdm2 (Barak et al. 1993). Therefore, elevated 
protein level of p53, such as in treated condition (Figure 12), might directly induce 
high mdm2 expression once apoptotic stimulus is removed, which can act as a rapid 
mechanism to enhance cellular survival. 
The other challenge the reversing cells faced was ER stress. ER is the first step of 
secretory pathway that performs processing on nascent polypeptides into mature 
forms, including folding and posttranslational modifications. When incoming nascent 
polypeptides exceeds processing capacity of ER, accumulation of unfolded proteins 
cause ER stress (Schroder et al. 2005). There were two possible sources for the ER 
stress in the study model. Protein synthesis might be enhanced as the cells needed to 
rebuild the cellular structure and organelles. However, neither GO terms related to 
positive nor negative regulation of protein biosynthesis were found. More detailed 
biochemical analysis is needed. The other source is the fragmentation of ER network, 
which also occurs in the execution phase of apoptosis (Taylor et al. 2008) and reduces 
ER processing capacity (Ron et al. 2007). Since apoptosis generates a massive 
amount of degraded protein (Taylor et al. 2008; Liithi et al. 2007) it is expected that 
cellular degradation systems are engaged to clear the debris in the reversing cells. 
However, the GO analysis shows that one of the two major degradation systems 
ubiquitin- proteosome degradation system, which is also responsible to remove 
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mis folded proteins (McClcllan ct al. 2005) was engaged during the reversal proccss 
(Figure 11H). Hence, protein metabolic pathways would be expectcd to be under 
severe stress and become a vulnerable target in the reversing cells. As expected, 
inhibition of HSP90, functional in both ubiquitin- proteosome degradation and protein 
folding in ER (Wang et al. 2006; Argon et al. 1999; McClellan et al. 2005), led to the 
revering cells to terminal death (Figures 13 and 14). Nevertheless, without interfering 
either the anti-apoptotic, DNA repairing or protein metabolic mechanisms, the 
apoptotic cells could revert to healthy non- apoptotic state. 
4.5 Summary 
Together with the previous study from our laboratory (Tang et al. 2009), the data in 
this thesis demonstrate that mammalian cells possess an intrinsic mechanism that 
allows a cell to reverse from execution phase of apoptosis (Figures 2- 5). The data 
also suggest that the mechanism could potentially influence a cell's behavior (Figure 
8) through altering its genetic content (Figures 6, 7), which is in agreement with the 
hypotheses put forward by (Vaughan et al. 2002; Albeck et al. 2008). Nevertheless, it 
might not be too surprising that a cell can recover from partial apoptotic damage. As 
discussed by Eldar et al. (2010), apoptotic cell death is in fact a type of terminal 
differentiation. This mode of differentiation, termed procrastination, is characterized 
by deferring the commitment to differentiate and such a cell has a tendency to revert 
to its original state when environment no longer favors the differentiated phenotype 
(in this case, being apoptotic and dead). In other kinds of state switching (e.g. 
switching between glucose and galactose as an energy source of a bacterial cell, 
reviewed in Sinits et al. (2006)), a cell can switch rather freely back- and- forth 
between states (Acar et al. 2008). However, in the case of cell death, apoptotic 
68 
damaging events leave persistent alterations, producing gcnctic rearrangements, in a 




5.1 Could reversal of apoptosis be evolutionarily advantageous? 
Is the phenomenon reversal of apoptosis observed in these mammalian cells an 
accidental failure in coinciding the point of commitment before the start of 
destruction, or, in fact, a functional process in vivol More experiments are required to 
answer this question. However, from the perspective of evolution, gene network is 
postulated as the ultimate target that natural forces select, rather than the organism 
that carries (Dawkins 2006). Reversal of apoptosis from late -stage apoptosis provides 
a source to "reshuffling" the contents and gives a gene network more forms of 
expression (phenotypic diversity) from originally identical genomes. The gene 
network, as a result, may better utilize environmental resources and be better fit to 
changing environment, thus, to propagate its carrier (the cell). 
While the purpose of such a "selfish" gene network to increase its presence 
may not match the interest of a multi- cellular organism, the phenomenon may have 
evolutionary advantages for primitive organisms with less complexity. In fact, there is 
evidence that this phenomenon could be evolutionary conserved. A previous study 
(Reddien et al. 2001) using C. elegans mutant without the "eat me" signal finds that, 
during its embryogenesis, some cells normally programmed to die display apoptotic 
morphology (nuclear condensation) and later recover and survive. In this case, aside 
from the deletion of the gene to send out "eat me" signal, the apoptotic circuitry is 
essentially intact, suggesting that the ability to reverse apoptosis is encoded in C. 
elegans' genome and can possibly be found in other organisms in vivo. Based on this 
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observation, 1 hypothesize that the phenomenon will be more readily observed in 
organisms that have lesser requirement of tissue integrity to maintain the organism's 
functioning, such as plants and unicellular organisms, like yeast and slime molds (all 
of which also show apoptosis-like cell death programmes, reviewed in Ameisen 
(2002); Deponte (2008)); and reversal of apoptosis may represent a evolutionary 
remnant that is not completely eradicated in mammalian genome. 
5.2 Reversal of apoptosis as an "individualistic" behavior against organismal 
integrity 
The topic of "individuality" versus organismal integrity in socioevolution is gathering 
attention in the study of biological noise (reviewed in Eldar et al. (2010); Balazsi et al. 
(2011)) that may offer insights in studying reversal of apoptosis. The noise here is 
defined as stochastic, rather than deterministic, variation of phenotypes within a 
genetically identical cell population. In simple organisms, biological noise is well-
studied. Bacterial cells are known to make use of stochastic variation of gene 
expression among individual cells to assume various phenotypes to fully exploit 
diverse environmental resources (reviewed in Eldar et al. (2010); Balazsi et al. 
(2011)). Such a source of non- deterministic variation of cell fates is assumed 
detrimental to higher organisms. Mechanisms have evolved to suppress biological 
noise in higher organisms (Arias et al. 2006). However, a recent study demonstrates a 
role of stochastic variation in the compound eye development of drosophila (Boettiger 
et al. 2009), leading to a proposal that biological noise is least suppressed in tissue 
development where an ordered, deterministic pattern is not required. 
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Similarly, "individualistic" behavior like reversing apoptosis with the potential 
of phenotypic variation should be normally suppressed. However, as shown in the 
study of C. elegans by (Reddien et al. 2001), cells could survive apoptosis when the 
signal to attract immune system's attention is lost. Cells that have evaded apoptosis 
and immunity's clearance may acquire new phenotype not compatible with the whole 
organism, such as uninhibited growth, as shown in the transformation assay of this 
study (Figure 8). In support with the potential role of reversal of apoptosis in 
carcinogenesis, which is a form of evolutionary process (Stratton et al. 2009), a 
genomics study finds that, in 2-3% of all cancers, large-scale genomic rearrangements 
are triggered by single events, contrasting the conventional notion of gradual 
accumulation of mutations (Stephens et al. 2011). The source that induces such 
massive genomic rearrangement remains to be determined. Apoptosis, which cleaves 
DNA into fragments, could be a potential candidate; whereas reversal of apoptosis 
serves to preserve an apoptotic cell and its genome. 
5.3 Proposed studies 
5.3.1 Other apoptotic targets that may leave persistent effects 
In addition to genetic material, other cellular components targeted in apoptosis could 
be subjects of study on potential consequences in cells that survive execution phase of 
apoptosis. Cytoskeletal architecture could be incompletely repaired before initiation 
of cell division, which may resume as soon as within a couple of hours after removing 
inducer (unpublished data). Disrupted cytoskeletal structure is known to destabilize 
cell division and cause non-equal partitioning of genetic material during nuclear 
division (reviewed in Kunda et al. (2009)). Also, cleaved apoptotic fragments may 
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interfere the normal functioning of its full form, as in the case of PARP, which 
mediates DNA damage response by poly(ADP-ribosyl)ation (Olivera ct al. 1982; 
Mortusewicz et al. 2007). The non- functional fragment of PARP without poly(ADP-
ribosyl)ation activity competitively bind to DNA damage site against the full form to 
prevent the latter from initiate proper repairing mechanism (Yung et al. 2001). These 
damaging events can alter the behaviors of the survived cells and, possibly, its 
descendents. 
A recent surprising observation on caspase proteolysis is that cleavage of 
many substrates generates stable and putatively functional fragments (Dix et al. 
2008). A subset of them is kinase/ phosphatase (reviewed in Kurokawa et al. (2009)), 
an important group of signaling molecules which, after modification by caspase, may 
persistently alter cellular behaviors. An interesting substrate is ROCK kinase, a 
protein mediating the membrane blebbing in apoptosis (Coleman et al. 2001; Sebbagh 
et al. 2001) and, in other contexts, cell mobility through changing cell contractability 
(Sahai et al. 2002). Caspase cleavage removes its inhibitory domain and generates a 
constitutively active kinase. It is conceivable that cell with caspase- mediated cleaved 
ROCK kinase will have dysregulated cell contractability and probably mobility 
(Coincidently，a recent review by Fackler et al. (2008) suggests ROCK-mediated non-
apoptotic blebbing as a mechanism for cell migration). However, one of the 
challenges of studies in this direction is that the complete set of caspase substrates 
remains to be established. Also, the causality between cleaved substrates and 
apoptotic phenotypes are often inferred (e.g. from healthy cells expressing cleaved 
proteins), rather than in vivo demonstrated. 
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5.3.2 Post- caspase activation regulation of apoptosis 
Another area of study the findings in this thesis may open up is the post-caspasc 
activation regulation of apoptosis. Many kinases after caspase processing are pro-
apoptotic. They are currently thought not needed to commit or drive a cell to death 
(Kurokawa et al. 2009). This current study implies they are indeed needed. 
Identifying their anti-apoptotic partners and studying their interactions will help 
decipher the dynamics of apoptotic cell death. 
5.3.3 Identifying correlation between reversal of apoptosis and cancer 
Majority of spontaneous cancers arise from accumulating somatic mutations (Stratton 
et al. 2009). Findings in this study suggest a mechanism to cause mutations through 
apoptotic nuclease -mediated DNA cleavage. Aside from failing to join to the original 
DNA segment (and thus lost in subsequent cell division), cleaved DNA fragments 
may misjoin and thus form translocation, the main form of mutation found 
responsible for all types of cancer (Futreal et al. 2004). To further test the contribution 
of reversal of apoptosis in carcinogenesis, it would be worthwhile to perform a 
genome- wide comparison between the sites of breakpoint in cancer patients and the 
sites of DNA cleavage by apoptotic DNase as apoptotic DNases have preferred DNA 
sequences of cleavage (Widlak et al. 2000; Liu et al. 2003). A previous in vitro study 
may have provided preliminary evidence (Sim et al. 2001). Using population 
analyses, the authors observe that some anticancer drugs induce a coappearance of 
apoptotic nucleosomal ladder and cleavage within mixed lineage leukemia (MLL) 
gene, a gene frequently rearranged in therapy-related acute myeloid leukemia (t-
AML). The drugs themselves are genotoxic, inducing DNA breaks. To clarify the 
source of damage, the authors apply inhibitor of caspase activity and find that the 
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clcavagc within MLL is caspase- dependent, suggesting the role of apoptotic nuclease 
in breaking the gene. The data are inconclusive to claim that surviving apoptosis 
mediates the genetic alterations in clinical cases. However, when locations of 
apoptotic cleavage and translocation hotspots in cancer are comprehensively mapped, 
a comparison may potentially point to the types of cancer to which reversal of 
apoptosis contributes. 
5.3.4 Single cell methods and cell tracking system for further studies 
Removing an unwanted cell with apoptosis is actually a process involving the about-
to-die cells themselves and their neighbors, even in unicellular organisms. Therefore, 
studies carried out in a similar context would capture the essences of the apoptotic 
process. However, the inherent asynchronous nature of apoptosis and the 
inaccessibility to probe cells in intact organisms pose problems to population 
approaches. The fact that anti-mitotic drugs induce multiple diverse cell fates among a 
cell population makes identifying cells that have actually survived apoptosis difficult 
(Gascoigne et al. 2008), and changes in cells of interest may be obscured by cells 
assuming different fates. Therefore single cell methods and a cell tracking system are 
in need to reduce heterogeneity among samples. A cell tracking system that worth 
consideration to adopt (e.g. in Mattheakis et al. (1999)) is one that converts transient 
cell signaling event to permanent genetic fluorescent marker. The transient caspase 
proteolytic activity may serve as the transient signaling event. 
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5.3.5 Notes on studying reversal of apoptosis in relation to phagocytosis 
Clearance of apoptotic cells is generally effective in vivo, even in tissue with a large 
apoptotic population (Siirh et al. 1994), and dying cells are known to be engulfed 
even before exhibiting morphological markers of apoptosis (Parnaik et al. 2000; 
Wiegand et al. 2001). However, a study (Wiegand et al. 2001) shows that the kinetics 
of clearance varies in the apoptosis triggered by different inducers and suggests that 
the efficiency is pathway-dependent. A cell can be engulfed as late as after having 
shown apoptotic and then secondary necrotic signs. Those inducers and the apoptotic 
pathways involved may represent scenarios in which cells are more prone to escape 
execution in vivo. Lastly, given that phagocytosis is an alternative path to remove 
unwanted cell in multi- cellular organisms, manipulating the process of clearing 
apoptotic dead cells can be an equally effective way to drive cells to dead as directly 
manipulating the apoptotic pathway. 
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